The deal that was announced in November 2024 is worth USD 233m and involves the delisting of the US company
Innovative Italian healthcare companies find support in the European organisation's initiatives
The financial platform with its headquarters in Germany now has the SBI Group as majority shareholder
Biotech scaleup develops innovative solutions for breast reconstruction and appoints Sanjay Kakkar as new CEO
The exit has an initial value of USD 250 million, which may rise to USD 752.5 million, and will be finalised by the second half of 2025
Growth is 28% compared to 2023, the number of rounds also grows to 417 with a growth of 31%.
Capital leverages Lombardy Region fund, scaleup develops active automotive solutions
Click here to read previous Newsletters
Subscribe to the newsletter
yes
en
* I agree that my personal data will be used in accordance with the Privacy and Cookie Policy.
* I authorize the processing of my personal data to be updated on new arrivals and for direct marketing purposes related to the services offered.